Overview

Evaluate the Efficacy and Safety of Large-Scale Field-Directed Topical Therapy of Actinic Keratosis of the Chest w/Ingenol Mebutate 0.015%

Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
Evaluate the Efficacy and Safety of Large-Scale Field-Directed Topical Therapy of Actinic Keratosis of the Chest w/Ingenol Mebutate 0.015%
Phase:
Phase 4
Details
Lead Sponsor:
Goldman, Butterwick, Fitzpatrick and Groff
Collaborator:
LEO Pharma